Why is Zhejiang Dayang Biotech Group Co., Ltd. ?
1
With a growth in Net Profit of 48.92%, the company declared Very Positive results in Sep 25
- ROCE(HY) Highest at 8.71%
- RAW MATERIAL COST(Y) Fallen by -23.88% (YoY)
- INVENTORY TURNOVER RATIO(HY) Highest at 6.24 times
2
With ROE of 7.52%, it has a very attractive valuation with a 2.50 Price to Book Value
- Over the past year, while the stock has generated a return of 44.51%, its profits have risen by 39.7% ; the PEG ratio of the company is 0.8
- At the current price, the company has a high dividend yield of 0.7
3
Market Beating performance in long term as well as near term
- Along with generating 44.51% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you buy?
- Overall Portfolio exposure to Zhejiang Dayang Biotech Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Dayang Biotech Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhejiang Dayang Biotech Group Co., Ltd.
44.22%
1.77
44.87%
China Shanghai Composite
15.17%
1.02
14.86%
Quality key factors
Factor
Value
Sales Growth (5y)
6.86%
EBIT Growth (5y)
2.72%
EBIT to Interest (avg)
10.37
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
0.66
Tax Ratio
10.04%
Dividend Payout Ratio
39.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.61%
ROE (avg)
7.03%
Valuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
2.50
EV to EBIT
36.85
EV to EBITDA
19.30
EV to Capital Employed
2.52
EV to Sales
2.79
PEG Ratio
0.84
Dividend Yield
0.75%
ROCE (Latest)
6.85%
ROE (Latest)
7.52%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
12What is working for the Company
ROCE(HY)
Highest at 8.71%
RAW MATERIAL COST(Y)
Fallen by -23.88% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 6.24 times
NET PROFIT(Q)
Highest at CNY 29.9 MM
EPS(Q)
Highest at CNY 0.36
-4What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 2,141.24
OPERATING PROFIT(Q)
Lowest at CNY 20.14 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 8.21 %
Here's what is working for Zhejiang Dayang Biotech Group Co., Ltd.
Net Profit
Highest at CNY 29.9 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY 29.9 MM has Grown at 52.3%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.36
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 6.24 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -23.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhejiang Dayang Biotech Group Co., Ltd.
Interest Coverage Ratio
Lowest at 2,141.24
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 20.14 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 8.21 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales






